Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. by West, N, Hegazy, A, Owens, B, Bullers, S, Linggi, B, Buonocore, S, Coccia, M, Görtz, D, This, S, Stockenhuber, K, Pott, J, Friedrich, M, Ryzhakov, G, Baribaud, F, Brodmerkel, C, Cieluch, C, Rahman, N, Müller-Newen, G, Owens, R, Kühl, A, Maloy, K, Plevy, S, Oxford IBD Cohort Investigators, Keshav, S, Travis, S, Powrie, F